TULIP: A New Approach to IOP Reduction - Summary - MDSpire
Feature

TULIP: A New Approach to IOP Reduction

Low-power ultrasound biomodulation may offer a noninvasive, repeatable strategy to lower IOP without tissue destruction.

Share

Low-power ultrasound biomodulation presents a promising noninvasive strategy for lowering intraocular pressure (IOP) in glaucoma patients, a leading cause of irreversible blindness. The investigational Therapeutic Ultrasound to Lower Intraocular Pressure (TULIP) utilizes a handheld transducer to influence aqueous humor dynamics without tissue damage. Initial clinical evaluations showed a significant reduction in IOP with minimal side effects, indicating its potential as a repeatable and safe treatment option within evolving glaucoma management protocols.

Original Source(s)

TULIP: A New Approach to IOP Reduction

  • by Donald Schwartz, MD

  • May 1, 2026

Related Content

GA Gene Therapy Interest Increases

Phase I trial results of PulseSight Therapeutics’ PST-611 to be presented at ARVO 2026

  • May 1, 2026

  • 2 min
Ocugen GA Trial Advances Toward Phase 3

Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy

  • May 1, 2026

  • 3 min
Emerging Technologies in Continuous IOP Monitoring

Wearable and implantable devices offer new data on pressure variability, though barriers to routine use persist.